The Competition Commission of Pakistan (CCP) imposed substantial fines on all GCC-approved medical centers and administrative offices for collusion. The centers were found to have fixed uniform fees, divided the market, and were exploiting customers “by restricting their choice and imposing unfair terms and conditions.” The activities served to guarantee revenues for the medical centers and also eliminated incentives to innovate and improve efficiency.
20 medical centers were each fined Rs20 million (211,864 USD) and five administrative offices were fined Rs10 million (105,932 USD) for their participation.
Full content: Tribune
Related content: Competitor Collaborations in Health Care: Understanding the Proposed ACO Antitrust Review Process
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Unions & SMBs Urge Congress for Antitrust Funding Boost
Apr 16, 2024 by
CPI
DirecTV to Appeal Court Decision in Antitrust Challenge Against Nexstar
Apr 16, 2024 by
CPI
EU Cybersecurity Label Vote Delayed Amidst Big Tech Debate
Apr 16, 2024 by
CPI
US DOJ to Sue Live Nation for Alleged Antitrust Violations
Apr 16, 2024 by
CPI
Japan Probes Google for Alleged Ad Monopoly
Apr 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI